High- and Low-risk Actinic Keratosis Referrals to Secondary Care
1 other identifier
observational
3,379
1 country
1
Brief Summary
This study evaluates the implementation of the General Practitioners guidelines 'Suspicious Skin Lesions' and investigated whether their publication and implementation has led to a reduction in the proportion of referrals of low-risk patients with actinic keratosis to secondary care, after publication of the General Practitioners guidelines and implementation activities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
July 20, 2023
CompletedFirst Posted
Study publicly available on registry
August 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedApril 4, 2025
April 1, 2025
2.5 years
July 20, 2023
April 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in proportion of low-risk actinic keratosis patients among all actinic keratosis patients.
The change in proportion of low-risk actinic keratosis patients among all actinic keratosis patients referred by the general practitioner to the dermatologist. The definition of low-risk actinic keratosis patients was based on the General Practitioners guidelines 'Suspicious skin lesions' (published in 2017). Patients were defined as low-risk when they were not immunocompromised, did not have a cutaneous malignancy in their medical history, did not have previous treatment or if they did not have extensive lesions.
2018 compared to 2019 (2 years)
Study Arms (2)
Low risk patients
Low risk actinic keratosis patients referred by the general practitioner and diagnosed as actinic keratosis by the dermatologist in 2018 and 2019.
High risk patients
High risk actinic keratosis patients referred by the general practitioner and diagnosed as actinic keratosis by the dermatologist in 2018 and 2019.
Eligibility Criteria
Data from patients are collected retrospectively using the Electronic health records. Patients were selected based on the diagnosis-treatment-combination (DTC) 17 (premalignant lesion) and DTC 14 (cutaneous malignancy) that was registered from January 2018 to December 2019 by the dermatologist.
You may qualify if:
- patients of 18 years and older
- referred to dermatologist for suspicion of actinic keratosis and diagnosed as actinic keratosis by the dermatologist
- treated at MaastrichtUMC+ or TergooiHospital
You may not qualify if:
- different diagnosis than actinic keratosis
- referred by a different specialist than the general practitioner
- referred with multiple problems
- referred for a second opinion
- if the patients was treated as different diagnosis than actinic keratosis by general practitioner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maastricht University Medical Centerlead
- Tergooi Hospitalcollaborator
Study Sites (1)
Ellen Oyen
Maastricht, Netherlands
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Klara Mosterd, prof.dr.
Maastricht UMC+
- PRINCIPAL INVESTIGATOR
Maud Jansen, dr.
Maastricht UMC+
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2023
First Posted
August 4, 2023
Study Start
March 1, 2021
Primary Completion
September 1, 2023
Study Completion
December 1, 2025
Last Updated
April 4, 2025
Record last verified: 2025-04